Year of creation : 2015
Status: simplified joint stock company
Workforce: 5
% of the turnover dedicated to R&D: 16%
% of the turnover dedicated to innovation: 20%
Number of patents: 1

CONTACT DETAILS
20 rue Arsene Vermenouze
63200 Riom
France
CONTACT
Didier Hatsch
Phone: +33 (0) 415 470 015
Email: contact@biosilicium.fr
Website: www.biosilicium.fr
BioSilicium
Publisher of expert software packages for monitoring, traceability, and quality.
BioSilicium is a publisher of expert software packages for monitoring, traceability and quality. Its approach is to provide companies with solutions adapted and optimised to their needs. Its expertise is available in different areas: forensics, quality and health & safety.
In the forensic field, we publish two software: bs-LIMS and bs-SEAL. bs-LIMS enables the management of all the information and processes of entities such as genetic identification laboratories, toxicology laboratories and forensic medicine departments. bs-LIMS meets all the requirements for 17025 accreditation. bs-SEAL is an expert system enabling the statistical evaluation of genetic profiles in the context of parentage or mixing. The merger of the two products allows us to offer a complete solution for national DNA databases including parentage searches. In the forensic field, our R&D provides a portfolio of artificial intelligences applied in forensic medicine, some of which are in production.
In the field of quality and health & safety, we publish the bs-QHSE platform. This platform covers all QHSE processes through a very wide range of à la carte modules. For example: quality management, management of the single risk assessment document, accidentology, prevention plans and many others. bs-QHSE is available as a secure HDS SAAS service and can be adapted à la carte to very small companies as well as to international groups. With bs-QHSE, our ambition is to democratise the digitalisation of QHSE processes and participate in active prevention within companies.
Issued by our R&D, our artificial intelligence development process can be implemented in the analysis of biotechnology platform data or living data and then directly integrated into business modules within our management software packages.